» Authors » Jason Klapman

Jason Klapman

Explore the profile of Jason Klapman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 634
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
McNamara G, Ali K, Vyas S, Huynh T, Nyland M, Almanza D, et al.
Gastrointest Disord (Basel) . 2020 Jul; 1(1):106-119. PMID: 32601617
Pancreatic cancer (PC), a leading cause of cancer-related deaths in the United States, is typically diagnosed at an advanced stage. To improve survival, there is an unmet need to detect...
12.
Saller J, Al Diffalha S, Neill K, Bhaskar R, Oliveri C, Boulware D, et al.
Dig Dis Sci . 2019 Nov; 65(7):1992-1998. PMID: 31691172
Background: CDX-2 is a nuclear homeobox transcription factor not normally expressed in esophageal and gastric epithelia, reported to highlight intestinal metaplasia (IM) in the esophagus. Pathological absence of goblet cells...
13.
Machicado J, Klapman J, Wani S
Clin Gastroenterol Hepatol . 2019 Jun; 17(13):2827. PMID: 31220647
No abstract available.
14.
Machicado J, Obuch J, Goodman K, Schefter T, Frakes J, Hoffe S, et al.
Clin Gastroenterol Hepatol . 2019 May; 17(13):2749-2758.e2. PMID: 31042578
Background & Aims: Fiducial markers are inert radiopaque gold or carbon markers implanted in or near pancreatic tumor to demarcate areas for image-guided radiation therapy. Endoscopic ultrasound (EUS) pre-loaded fiducial...
15.
Wani S, Han S, Simon V, Hall M, Early D, Aagaard E, et al.
Gastrointest Endosc . 2019 Feb; 89(6):1160-1168.e9. PMID: 30738985
Background And Aims: Minimum EUS and ERCP volumes that should be offered per trainee in "high quality" advanced endoscopy training programs (AETPs) are not established. We aimed to define the...
16.
Wani S, Keswani R, Han S, Aagaard E, Hall M, Simon V, et al.
Gastroenterology . 2018 Jul; 155(5):1483-1494.e7. PMID: 30056094
Background & Aims: It is unclear whether participation in competency-based fellowship programs for endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) results in high-quality care in independent practice. We measured...
17.
Gangi A, Malafa M, Klapman J
Pancreas . 2018 Apr; 47(5):586-591. PMID: 29683970
Objectives: Pancreatic cancer (PC), a common cause of cancer death, is rarely diagnosed at an early stage. Early detection of PC may improve outcomes in affected patients. This study evaluated...
18.
Luu C, Amaral M, Klapman J, Harris C, Almhanna K, Hoffe S, et al.
World J Gastroenterol . 2018 Jan; 23(46):8193-8199. PMID: 29290655
Aim: To evaluate the accuracy of endoscopic ultrasound (EUS) in early esophageal cancer (EC) performed in a high-volume tertiary cancer center. Methods: A retrospective review of patients undergoing esophagectomy was...
19.
Marshall C, Mounzer R, Hall M, Simon V, Centeno B, Dennis K, et al.
Clin Gastroenterol Hepatol . 2017 Sep; 16(7):1114-1122.e2. PMID: 28911946
Background & Aims: Despite the widespread use of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) to sample pancreatic lesions and the standardization of pancreaticobiliary cytopathologic nomenclature, there are few data on inter-observer...
20.
Permuth J, Chen D, Yoder S, Li J, Smith A, Choi J, et al.
Sci Rep . 2017 Sep; 7(1):10484. PMID: 28874676
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease that lacks effective biomarkers for early detection. We hypothesized that circulating long non-coding RNAs (lncRNAs) may act as diagnostic markers of incidentally-detected...